TrialNet Chair Dr. Kevan Herold reflects on 2022— “a landmark year for T1D research”
TrialNet Chair Kevan C. Herold, MD, reflects on advances in type 1 diabetes research and the need to continue testing promising treatments.
Dear TrialNet Family,
Growing up with TrialNet — Screened as children and now in their 20s, two Abatacept Prevention Study participants share their stories
As we near the release of findings from the Abatacept Prevention Study, two participants share how their experiences in TrialNet research helped shape their futures.
Meet TrialNet hero: Orlando Brown, Jr.
Meet Orlando Brown, Jr.: You may recognize the Kansas City Chiefs offensive tackle, also known as “Zeus”. It’s evident why, especially on the gridiron. More than 350 pounds of superhuman muscle and momentum sprinting downfield, Orlando inherited the name and strength of his father, also an NFL hero.